PILLvsQLDETF Comparison
Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF
Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (PILL) and ProShares Ultra QQQ ETF (QLD) belong to the same industry segment: Leveraged Equity. PILL is more expensive with a Total Expense Ratio (TER) of 1.22%, versus 0.98% for QLD. PILL is up 13.5% year-to-date (YTD) with -$4M in YTD flows. QLD performs better with 22.46% YTD performance, and +$846M in YTD flows. Run a side-by-side ETF comparison of PILL and QLD below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
PILL vs QLD performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PILL QLD | -17.44%-10.38% | -27.84%+1.40% | +13.50%+22.46% | +68.88%+22.22% | +170.70%+198.35% | -20.60%+114.74% |
| Flows | PILL QLD | -$774K+$211M | -$774K+$730M | -$4M+$846M | -$3M+$1.32B | -$7M+$1.18B | -$17M+$1.72B |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PILL QLD | +67.58%+37.82% | +69.65%+39.95% | +62.47%+41.17% | +63.79%+46.40% |
| Max drawdown | PILL QLD | -44.35%-14.47% | -44.35%-25.08% | -60.51%-42.40% | -82.09%-63.41% |
| Max drawdown duration | PILL QLD | 65d17d | 65d169d | 375d212d | 1743d878d |
PILL | QLD | |
Last sale 10/23/2026 at 1:30 PM | $13.90 | $86.15 |
| Previous close 10/22/2026 | $15.08 | $86.26 |
| Consolidated volume 10/22/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
PILL | QLD | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
PILL | QLD | |
|---|---|---|
| Last price | $13.90 | $86.15 |
| 1D performance | -7.82% | -0.13% |
| AuM | $14.58 M | $13.72 B |
| E/R | 1.22% | 0.98% |
Exposure data will be available soon
